Home » This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout

Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threat. WIRED Read More 

 Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threat.